Pulse.ng logo
Go

Valeant in talks to buy Egyptian drugmaker Amoun Pharma: Bloomberg

  • Published:
The sign of Valeant Pharmaceuticals International Inc is seen at its headquarters in Laval, Quebec May 19, 2015. REUTERS/Christinne Muschi play The sign of Valeant Pharmaceuticals International Inc is seen at its headquarters in Laval, Quebec May 19, 2015. REUTERS/Christinne Muschi
24/7 Live - Subscribe to the Pulse Newsletter!

(Reuters) - Valeant Pharmaceuticals International Inc is in talks to buy Egyptian drugmaker Amoun Pharmaceutical Co to expand its veterinary and human medicines portfolio, Bloomberg reported, citing people familiar with the matter.

A sale could value Amoun at $700 million to $800 million, Bloomberg reported. (http://bloom.bg/1EXe5PQ)

Valeant was not immediately available for comment.

Should Amoun fail to find a buyer, it may consider an initial public offering in London, the report said.

Amoun could not be immediately reached for comment.

Do you ever witness news or have a story that should be featured on Pulse Nigeria?
Submit your stories, pictures and videos to us now via WhatsApp: +2349055172167, Social Media @pulsenigeria247: #PulseEyewitness & DM or Email: eyewitness@pulse.ng. More information here.